| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2022 | Feb 27, 2023 | Freeman Mason Chief Medical Officer | Sell | Cincor Pharma, Inc. | CINC | $15.21 | $91 | -0 |
| Jan 11, 2022 | Jan 13, 2022 | Freeman Mason EVP Clinical Development | Buy | Cincor Pharma, Inc. | CINC | $16 | $41,600 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.